• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechData Sheet

IBM’s new health care prescription: A standalone business unit

By
Heather Clancy
Heather Clancy
Down Arrow Button Icon
By
Heather Clancy
Heather Clancy
Down Arrow Button Icon
April 13, 2015, 5:01 PM ET
Video Poster

IBM is taking a far more holistic approach to health care.

Its data analytics software already figures in prominent medical research trials with the Cleveland Clinic, Mayo Clinic, and Sloan Kettering. Now, IBM is turning the underlying Watson technology into a cloud service, Watson Health Cloud, it will sell to doctors, hospitals, insurers and patients. That offering will be the centerpiece of a new dedicated, Boston-area business unit, IBM Watson Health.

“We are going into the health care business in a big way,” IBM Senior Vice President John Kelly told Fortune. “We all recognize that outcomes aren’t what we hope for. Costs are skyrocketing. On the other side, so much data is collected. … We want to provide better insights, for better outcomes.”

IBM estimates that between electronic medical records, digitized diagnostics, and wearable medical devices, the average person will leave a trail of more than 1 million gigabytes of health-related data in their lifetime. The goal of IBM’s new business unit is to turn that information into something useful.

“This platform, in the not so distant future, will become the largest site of health care data in the world,” Kelly said.

Apple, Johnson & Johnson, and Medtronic are three prominent early partners that will use Watson Health Cloud as the foundation for their own medical intelligence services. The platform will underlie Apple’s HealthKit and REsearchKit applications; J&J will use it to create mobile apps that coach caregivers on pre-operative and post-operative procedures; and Medtronic will create a service for diabetes patients.

“We have a line at the door,” Kelly said, hinting that additional partnerships are soon to come.

IBM’s new division will quickly grow to 2,000 people, led by senior vice president Michael Rhodin. That includes consulting experts and up to 200 researchers who will move from other business units, Kelly said. One thing that won’t be moved (at least not yet): IBM systems and hardware for health care records.

The company is also staffing up through acquisitions. Among those disclosed this week: Explorys, a cloud services spinoff from the Cleveland Clinic that serves 26 health care systems; and Phytel, which sells patient management software.

More doctors than ever consider themselves proficient with electronic medical records, but find their existing options difficult to use, according to an Accenture survey of more than 2,600 physicians released Monday. The number who recommend gadgets for collecting personal health data has tripled; more than 80% encourage patients to take a role in updating their medical records.

“The industry needs to adapt to a new generation of patients who are taking proactive roles in their health care and expect to have real-time data at their fingertips,” said Kaveh Safavi, an Accenture consultant.

IBM’s revelation coincides with the health care industry’s biggest annual technology conference, taking place this week in Chicago. The sector spent approximately $60 billion on information technology in 2014. One notable investment area is cognitive computing to automate diagnostics and patient care decisions. “Because the stakes are so high to improve health care outcomes and economics, Forrester [Research] believes it will be the first industry to benefit from cognitive solutions,” notes the research firm in a February report about artificial intelligence.

Three major areas of focus for the next five years:

  1. Applications for clinical automation
  2. Software that helps eliminate medical fraud and waste
  3. Personal solutions that help patients manage their own health

Sign up for Data Sheet, our daily newsletter about the business of technology.

About the Author
By Heather Clancy
See full bioRight Arrow Button Icon

Latest in Tech

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Tech

AIOpenAI
OpenAI forecasts its revenue will top $280 billion in 2030
By Shirin Ghaffary and BloombergFebruary 20, 2026
8 hours ago
Country representatives hold up letters supporting the Pax Silica effort.
EconomyTariffs and trade
India joins U.S. ‘Pax Silica’ semiconductor alliance easing tariff and energy tensions
By Rajesh Roy and The Associated PressFebruary 20, 2026
13 hours ago
elon musk
Future of WorkElon Musk
Elon Musk bans résumés and cover letters in hiring for his chip team. These are the 3 bullet points he’s looking for instead
By Jake AngeloFebruary 20, 2026
14 hours ago
AIAnthropic
Exclusive: Anthropic rolls out AI tool that can hunt software bugs on its own—including the most dangerous ones humans miss
By Sharon GoldmanFebruary 20, 2026
14 hours ago
Zuckerberg walks flanked by a man and a woman wearing Meta Ray-Ban glasses.
LawMeta
Mark Zuckerberg’s entourage threatened with contempt for wearing Meta AI glasses into a no-recording courtroom
By Jacqueline MunisFebruary 20, 2026
15 hours ago
AIMarkets
‘Doubts around the AI revolution are emerging,’ BofA says, as the market sees a ‘double-edged sword’ that could ‘cannibalize’ profits
By Nick LichtenbergFebruary 20, 2026
15 hours ago

Most Popular

placeholder alt text
Economy
Fed confirms it obeyed U.S. Treasury request for an unusual ‘rate check,’ weakening the dollar against foreign currencies
By Jim EdwardsFebruary 19, 2026
2 days ago
placeholder alt text
Success
'I had to take 60 meetings': Jeff Bezos says 'the hardest thing I've ever done' was raising the first million dollars of seed capital for Amazon
By Dave Smith and Fortune EditorsFebruary 19, 2026
2 days ago
placeholder alt text
AI
‘I’m deeply uncomfortable’: Anthropic CEO warns that a cadre of AI leaders, including himself, should not be in charge of the technology’s future
By Sasha RogelbergFebruary 19, 2026
2 days ago
placeholder alt text
AI
Deutsche Bank asked AI how it was planning to destroy jobs. And the robot answered
By Nick LichtenbergFebruary 18, 2026
2 days ago
placeholder alt text
AI
Sam Altman says the quiet part out loud, confirming some companies are ‘AI washing’ by blaming unrelated layoffs on the technology
By Sasha RogelbergFebruary 19, 2026
2 days ago
placeholder alt text
Asia
Bill Gates' foundation says sudden withdrawal was 'to ensure the focus remains on the AI Summit’s key priorities'
By The Associated PressFebruary 19, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.